Beranda › Kanker Payudara › New Jersey › Newark
Uji klinis Kanker Payudara di Newark, NJ
18 studi untuk Kanker Payudara mencari peserta di lokasi sekitar Newark (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Menerima pesertaFase 3
- Summit Health, Florham Park · 12 mi jauhnya
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Morristown Medical Center, Morristown · 17 mi jauhnya
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
Menerima pesertaFase 2
- Medical Oncology Hematology Associates, Newark
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
Menerima pesertaFase 1/2
- Summit Medical Group, Florham Park · 12 mi jauhnya
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Menerima pesertaFase 3
- Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey), Newark
- Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey), Livingston · 9 mi jauhnya
- Summit Medical Group PA, Florham Park · 12 mi jauhnya
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Menerima pesertaFase 3
- Summit Medical Group, Florham Park · 12 mi jauhnya
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Menerima pesertaFase 3
- Summit Medical Group, Florham Park · 12 mi jauhnya
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
Menerima pesertaStudi observasional
- Summit Medical Group, Florham Park · 12 mi jauhnya
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Menerima pesertaFase 3
- Newark Beth Israel Medical Center, Newark
- Cooperman Barnabas Medical Center, Livingston · 9 mi jauhnya
- Morristown Medical Center, Morristown · 17 mi jauhnya
A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
Menerima pesertaFase 2
- GSK Investigational Site, Morristown · 17 mi jauhnya
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Menerima pesertaFase 3
- Morristown Medical Center, Morristown · 17 mi jauhnya
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers
Menerima peserta
- Rutgers State University of New Jersey Medical School, Newark
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Menerima pesertaStudi observasional
- Morristown Medical Center, Morristown · 17 mi jauhnya
Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors
Menerima peserta
- Summit Health, Florham Park · 12 mi jauhnya
RADIANT: Pre-op Radiation With Abemaciclib and Letrozole
Menerima pesertaFase 1
- RWJBarnabas Health Clara Maas Medical Center, Belleville · 4 mi jauhnya
- Cooperman Barnabas Medical Center, Livingston · 9 mi jauhnya
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
Menerima pesertaFase 2
- RWJBarnabas Health - Newark Beth Israel Medical Center, Newark
DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment
Menerima pesertaFase 4
- Cancer Center Initiative, Newark
- University Hospital, Newark
- RWJBarnabas Health Newark Beth Israel Medical Center, Newark
- dan 2 lainnya
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Menerima pesertaFase 3
- Morristown Medical Center, Morristown · 17 mi jauhnya
Uji klinis Kanker Payudara di kota lain
- New York City, NY136 studi
- Houston, TX126 studi
- Boston, MA112 studi
- Nashville, TN81 studi
- Los Angeles, CA73 studi
- Edison, NJ68 studi
- St. Louis, MO64 studi
- Queens, NY64 studi
- Durham, NC64 studi
- Chicago, IL59 studi
- Philadelphia, PA56 studi
- Dallas, TX55 studi
Studi lain di Newark
- Cedera Sumsum Tulang Belakang13 studi
- Kanker Paru Non-Sel Kecil13 studi
- Leukemia Mieloid Akut12 studi
- Gagal Jantung10 studi
- Kanker Metastatik10 studi
- Penyakit Kardiovaskular9 studi
- Kanker Pankreas9 studi
- Melanoma8 studi
- Kanker (semua jenis)7 studi
- Kanker Paru7 studi
- Penyakit Crohn7 studi
- Stenosis Katup Aorta6 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.